YU8896A - Use of alendronate for preparation a medicament for lessening the risk of vetebral and nonvetebral fractures - Google Patents
Use of alendronate for preparation a medicament for lessening the risk of vetebral and nonvetebral fracturesInfo
- Publication number
- YU8896A YU8896A YU8896A YU8896A YU8896A YU 8896 A YU8896 A YU 8896A YU 8896 A YU8896 A YU 8896A YU 8896 A YU8896 A YU 8896A YU 8896 A YU8896 A YU 8896A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- alendronate
- fractures
- nonvetebral
- vetebral
- lessening
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Alendronat, jedan bisfosfonat, kada se primenjuje svakodnevno u toku bitnog perioda vremena, može da smanji razmeru kičmenih i ne-kičmenih preloma kod žena posle menopauze. Dalje, on može da smanji broj i ozbiljnost preloma. Isto tako, primena alendronata može da spreči deformitet kičme, i gubitak u visini.Alendronate, a single bisphosphonate, when administered daily over a significant period of time, can reduce the proportion of spinal and non-spinal fractures in post-menopausal women. Furthermore, it can reduce the number and severity of fractures. Likewise, administration of alendronate can prevent spinal deformity and height loss.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39046295A | 1995-02-17 | 1995-02-17 | |
US08/389,860 US20010051616A1 (en) | 1995-02-17 | 1995-02-17 | Method of lessening the risk of vertebral fractures |
US41963195A | 1995-04-10 | 1995-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU8896A true YU8896A (en) | 1999-12-27 |
Family
ID=27409915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU8896A YU8896A (en) | 1995-02-17 | 1996-02-16 | Use of alendronate for preparation a medicament for lessening the risk of vetebral and nonvetebral fractures |
Country Status (9)
Country | Link |
---|---|
AR (1) | AR002707A1 (en) |
CO (1) | CO4920257A1 (en) |
CZ (1) | CZ259097A3 (en) |
DZ (1) | DZ1991A1 (en) |
HR (1) | HRP960080A2 (en) |
IL (1) | IL117077A (en) |
PE (1) | PE46197A1 (en) |
TW (1) | TW453880B (en) |
YU (1) | YU8896A (en) |
-
1996
- 1996-02-08 IL IL11707796A patent/IL117077A/en unknown
- 1996-02-12 PE PE00009596A patent/PE46197A1/en not_active Application Discontinuation
- 1996-02-13 CZ CZ972590A patent/CZ259097A3/en unknown
- 1996-02-14 DZ DZ960032A patent/DZ1991A1/en active
- 1996-02-14 AR ARP960101382A patent/AR002707A1/en not_active Application Discontinuation
- 1996-02-15 CO CO96007058A patent/CO4920257A1/en unknown
- 1996-02-16 HR HRP960080 patent/HRP960080A2/en not_active Application Discontinuation
- 1996-02-16 YU YU8896A patent/YU8896A/en unknown
- 1996-02-28 TW TW085102340A patent/TW453880B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW453880B (en) | 2001-09-11 |
IL117077A (en) | 2002-08-14 |
PE46197A1 (en) | 1997-11-28 |
CO4920257A1 (en) | 2000-05-29 |
DZ1991A1 (en) | 2002-07-20 |
CZ259097A3 (en) | 1997-11-12 |
AR002707A1 (en) | 1998-04-29 |
IL117077A0 (en) | 1996-06-18 |
HRP960080A2 (en) | 1997-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL299814A1 (en) | Pharmaceutical preparation inhibiting depletion of human bone tissue | |
MY112915A (en) | Multiple unit tableted dosage form 1 | |
FR2720002B1 (en) | Incision device for the dermal administration of a medicament. | |
NO20053105D0 (en) | Oral, extended-release analgesic dosage form for administration ± once per day. day. | |
ZA967502B (en) | Medicament delivery device. | |
TW272940B (en) | / | |
GEP20063773B (en) | Steroid Sulphatase Inhibitors | |
EP0745401A3 (en) | Inhaler type medicine administering device | |
ZA953537B (en) | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
AU2711295A (en) | Combination treatment for inhibiting bone loss | |
DE59510333D1 (en) | PHARMACEUTICAL COMBINATION FOR HORMONAL CONTRACTION | |
AU3225993A (en) | Patient controlled bolus dosage infuser | |
WO1999004772A3 (en) | Use of levobupivacaine | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
GB9114493D0 (en) | Drug delivery system for administering growth factors | |
YU8896A (en) | Use of alendronate for preparation a medicament for lessening the risk of vetebral and nonvetebral fractures | |
AR059965A2 (en) | USE OF 8,9-DEHYDROESTRONE FOR THE PREPARATION OF AN ANTIOXIDANT MEDICINAL PRODUCT | |
DE69616591D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING MUIRAPUAMA AND PLANT WORMS | |
AU2691197A (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
SI0711163T1 (en) | Use of benzydamine in the treatment of pathological conditions caused by tnf | |
NO981320L (en) | Oral use of (+) - O-demethyltramadol as a pain reliever | |
MX9706275A (en) | Method of lessening the risk of vertebral fractures. | |
UA30722A (en) | Method for prophylaxis of festering-septic complications in parturient women | |
ITTO920146A1 (en) | MEDICAL PACKAGE FOR UROLOGICAL INTERVENTION. |